Makoto Endo

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Top Venues

British journal of cancer

Journal of clinical medicine

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kengo Kawaguchi, Kazuki Miyama, Makoto Endo, Ryoma Bise, Kenichi Kohashi, Takeshi Hirose, Akira Nabeshima, Toshifumi Fujiwara, Yoshihiro Matsumoto, Yoshinao Oda, Yasuharu Nakashima
Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma. NPJ precision oncology 8 (1) (2024)
Masaya Kanahori, Eijiro Shimada, Yoshihiro Matsumoto, Makoto Endo, Toshifumi Fujiwara, Akira Nabeshima, Takeshi Hirose, Kengo Kawaguchi, Ryunosuke Oyama, Yoshinao Oda, Yasuharu Nakashima
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8 + T cell infiltration. British journal of cancer 130 (7) (2024)
Masaya Kanahori, Eijiro Shimada, Yoshihiro Matsumoto, Makoto Endo, Toshifumi Fujiwara, Akira Nabeshima, Takeshi Hirose, Kengo Kawaguchi, Ryunosuke Oyama, Yoshinao Oda, Yasuharu Nakashima
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8 + T cell infiltration. British journal of cancer 130 (7) (2024)
Masaya Kanahori, Eijiro Shimada, Yoshihiro Matsumoto, Makoto Endo, Toshifumi Fujiwara, Akira Nabeshima, Takeshi Hirose, Kengo Kawaguchi, Ryunosuke Oyama, Yoshinao Oda, Yasuharu Nakashima
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8 + T cell infiltration. British journal of cancer 130 (7) (2024)
Masaya Kanahori, Eijiro Shimada, Yoshihiro Matsumoto, Makoto Endo, Toshifumi Fujiwara, Akira Nabeshima, Takeshi Hirose, Kengo Kawaguchi, Ryunosuke Oyama, Yoshinao Oda, Yasuharu Nakashima
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8 + T cell infiltration. British journal of cancer 130 (7) (2024)
Sakura Shiraishi, Toshifumi Fujiwara, Akira Nabeshima, Keiichiro Iida, Makoto Endo, Yoshihiro Matsumoto, Yoshinao Oda, Yasuharu Nakashima
Geriatric nutritional risk index as a predictor for surgical site infection in malignant musculoskeletal tumours of the trunk. Japanese journal of clinical oncology (2024)
Masaya Kanahori, Eijiro Shimada, Yoshihiro Matsumoto, Makoto Endo, Toshifumi Fujiwara, Akira Nabeshima, Takeshi Hirose, Kengo Kawaguchi, Ryunosuke Oyama, Yoshinao Oda, Yasuharu Nakashima
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8 + T cell infiltration. British journal of cancer (2024)
Kengo Kawaguchi, Kazuki Miyama, Makoto Endo, Ryoma Bise, Kenichi Kohashi, Takeshi Hirose, Akira Nabeshima, Toshifumi Fujiwara, Yoshihiro Matsumoto, Yoshinao Oda, Yasuharu Nakashima
Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma. NPJ precision oncology 8 (1) (2024)
Kengo Kawaguchi, Kazuki Miyama, Makoto Endo, Ryoma Bise, Kenichi Kohashi, Takeshi Hirose, Akira Nabeshima, Toshifumi Fujiwara, Yoshihiro Matsumoto, Yoshinao Oda, Yasuharu Nakashima
Viable tumor cell density after neoadjuvant chemotherapy assessed using deep learning model reflects the prognosis of osteosarcoma. NPJ precision oncology 8 (1) (2024)
Munehisa Kito, Keisuke Ae, Masanori Okamoto, Makoto Endo, Kunihiro Ikuta, Akihiko Takeuchi, Naohiro Yasuda, Taketoshi Yasuda, Yoshinori Imura, Takeshi Morii, Kazutaka Kikuta, Teruya Kawamoto, Yutaka Nezu, Ichiro Baba, Shusa Ohshika, Takeshi Uehara, Takafumi Ueda, Jun Takahashi, Hirotaka Kawano
Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group. Cancers 15 (8) (2023)
Takeshi Hirose, Masachika Ikegami, Shinya Kojima, Akihiko Yoshida, Makoto Endo, Eijiro Shimada, Masaya Kanahori, Ryunosuke Oyama, Yoshihiro Matsumoto, Yasuharu Nakashima, Akira Kawai, Hiroyuki Mano, Shinji Kohsaka
Extensive analysis of 59 sarcoma-related fusion genes identified pazopanib as a potential inhibitor to COL1A1-PDGFB fusion gene. Cancer science (2023)
Makoto Endo, Shinya Kawahara, Taishi Sato, Masami Tokunaga, Toshihiko Hara, Taro Mawatari, Tsutomu Kawano, Sadamoto Zenda, Tempei Miyaji, Mototsugu Shimokawa, Sanae Sakamoto, Toshio Takano, Masumi Miyake, Hiroyuki Aono, Yasuharu Nakashima, null null
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. BMJ open 13 (2) (2023)
Makoto Endo, Shinya Kawahara, Taishi Sato, Masami Tokunaga, Toshihiko Hara, Taro Mawatari, Tsutomu Kawano, Sadamoto Zenda, Tempei Miyaji, Mototsugu Shimokawa, Sanae Sakamoto, Toshio Takano, Masumi Miyake, Hiroyuki Aono, Yasuharu Nakashima, null null
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. BMJ open 13 (2) (2023)
Makoto Endo, Shinya Kawahara, Taishi Sato, Masami Tokunaga, Toshihiko Hara, Taro Mawatari, Tsutomu Kawano, Sadamoto Zenda, Tempei Miyaji, Mototsugu Shimokawa, Sanae Sakamoto, Toshio Takano, Masumi Miyake, Hiroyuki Aono, Yasuharu Nakashima, null null
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. BMJ open 13 (2) (2023)
Munehisa Kito, Keisuke Ae, Masanori Okamoto, Makoto Endo, Kunihiro Ikuta, Akihiko Takeuchi, Naohiro Yasuda, Taketoshi Yasuda, Yoshinori Imura, Takeshi Morii, Kazutaka Kikuta, Teruya Kawamoto, Yutaka Nezu, Ichiro Baba, Shusa Ohshika, Takeshi Uehara, Takafumi Ueda, Jun Takahashi, Hirotaka Kawano
Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group. Cancers 15 (8) (2023)
Makoto Endo, Shinya Kawahara, Taishi Sato, Masami Tokunaga, Toshihiko Hara, Taro Mawatari, Tsutomu Kawano, Sadamoto Zenda, Tempei Miyaji, Mototsugu Shimokawa, Sanae Sakamoto, Toshio Takano, Masumi Miyake, Hiroyuki Aono, Yasuharu Nakashima, null null
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee. BMJ open 13 (2) (2023)
Akira Kawai, Mikiya Ishihara, Tomoki Nakamura, Shigehisa Kitano, Shintaro Iwata, Kohichi Takada, Makoto Emori, Koji Kato, Makoto Endo, Yoshihiro Matsumoto, Shigeki Kakunaga, Eiichi Sato, Yoshihiro Miyahara, Kunihiko Morino, Shinya Tanaka, Shuichi Takahashi, Fujio Matsuo, Akihiko Matsumine, Shinichi Kageyama, Takafumi Ueda
Safety and Efficacy of NY-ESO-1 Antigen-specific T-cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yoshihiro Araki, Norio Yamamoto, Yoshikazu Tanzawa, Takahiro Higashi, Aya Kuchiba, Katsuhiro Hayashi, Akihiko Takeuchi, Shinji Miwa, Kentaro Igarashi, Makoto Endo, Eisuke Kobayashi, Hiroyuki Tsuchiya, Akira Kawai
Family cancer history and smoking habit associated with sarcoma in a Japanese population study. Scientific reports 12 (1) (2022)
Keiichiro Iida, Makoto Endo, Yosuke Susuki, Nobuhiko Yokoyama, Akira Maekawa, Akira Nabeshima, Keiichiro Iida, Toshifumi Fujiwara, Nokitaka Setsu, Tomoya Matsunobu, Yoshihiro Matsumoto, Ryohei Yokoyama, Yuichi Yamada, Kenichi Kohashi, Hidetaka Yamamoto, Yoshinao Oda, Yukihide Iwamoto, Yasuharu Nakashima
Clinical, Radiological, and Histopathological Characteristics of Periosteal Chondrosarcoma with a Focus on the Frequency of Medullary Invasion. Journal of clinical medicine 11 (7) (2022)
Eijiro Shimada, Makoto Endo, Yoshihiro Matsumoto, Kenji Tsuchihashi, Mamoru Ito, Hitoshi Kusaba, Akira Nabeshima, Tomoya Nawata, Akira Maekawa, Tomoya Matsunobu, Nokitaka Setsu, Toshifumi Fujiwara, Keiichiro Iida, Makoto Nakagawa, Takeshi Hirose, Masaya Kanahori, Ryunosuke Oyama, Taichi Isobe, Hiroshi Ariyama, Kenichi Kohashi, Hidetaka Yamamoto, Yoshinao Oda, Yukihide Iwamoto, Koichi Akashi, Eishi Baba, Yasuharu Nakashima
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients? Journal of clinical medicine 10 (21) (2021)
Tom Wei-Wu Chen, Angela Pang, Mark E Puhaindran, Myo Myint Maw, Herbert H Loong, Virote Sriuranpong, Chih-Chi Chang, Siyamol Mingmalairak, Takeshi Hirose, Makoto Endo, Akira Kawai, Mohamad Farid, Sze Huey Tan, Wei Lin Goh, Richard Quek, Jeffrey C H Chan, Alex K C Leung, Roger K C Ngan
The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium. Cancer science 112 (3) (2021)
Toshifumi Fujiwara, Toshihiro Ebihara, Kazuki Kitade, Nokitaka Setsu, Makoto Endo, Keiichiro Iida, Yoshihiro Matsumoto, Tomoya Matsunobu, Yoshinao Oda, Yukihide Iwamoto, Yasuharu Nakashima
Risk Factors of Periprosthetic Infection in Patients with Tumor Prostheses Following Resection for Musculoskeletal Tumor of the Lower Limb. Journal of clinical medicine 9 (10) (2020)